标题
Update on current and potential nanoparticle cancer therapies
作者
关键词
-
出版物
CURRENT OPINION IN ONCOLOGY
Volume 25, Issue 6, Pages 646-651
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-10-07
DOI
10.1097/cco.0000000000000012
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
- (2015) Mian M.K. Shahzad et al. NEOPLASIA
- Theranostic Nanoparticles with Controlled Release of Gemcitabine for Targeted Therapy and MRI of Pancreatic Cancer
- (2013) Gee Young Lee et al. ACS Nano
- pH-Responsive Assembly of Gold Nanoparticles and “Spatiotemporally Concerted” Drug Release for Synergistic Cancer Therapy
- (2013) Jutaek Nam et al. ACS Nano
- Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis
- (2013) Shixian Huang et al. ACS Nano
- Targeted Nanoparticles Assembled via Complexation of Boronic-Acid-Containing Targeting Moieties to Diol-Containing Polymers
- (2013) Han Han et al. BIOCONJUGATE CHEMISTRY
- Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
- (2013) Mark Katakowski et al. CANCER LETTERS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
- (2013) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Nanoparticle Delivered Vascular Disrupting Agents (VDAs): Use of TNF-Alpha Conjugated Gold Nanoparticles for Multimodal Cancer Therapy
- (2013) Mithun M. Shenoi et al. MOLECULAR PHARMACEUTICS
- Therapeutic nanoparticles in clinics and under clinical evaluation
- (2013) Catherine A Schütz et al. Nanomedicine
- Biomimetic, synthetic HDL nanostructures for lymphoma
- (2013) S. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
- (2013) D. T. Wiley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics
- (2013) G. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection
- (2012) Zeyu Xiao et al. ACS Nano
- Nanosized Multifunctional Polyplexes for Receptor-Mediated SiRNA Delivery
- (2012) Christian Dohmen et al. ACS Nano
- Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery
- (2012) Marina G. Damiano et al. ADVANCED DRUG DELIVERY REVIEWS
- A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer
- (2012) Peter J. Hosein et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial
- (2012) Ó Arrieta et al. BRITISH JOURNAL OF CANCER
- Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study
- (2012) David S. Alberts et al. GYNECOLOGIC ONCOLOGY
- Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type
- (2012) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Liposomal Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone in AIDS-Related Lymphoma: AIDS Malignancy Consortium Study 047
- (2012) Alexandra M. Levine et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: In vitro and in vivo studies
- (2012) Hongfang Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing
- (2012) Stuart S. Dunn et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antibody-Linked Spherical Nucleic Acids for Cellular Targeting
- (2012) Ke Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles
- (2012) Pedro M Valencia et al. Nanomedicine
- Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
- (2012) Hyukjin Lee et al. Nature Nanotechnology
- Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
- (2012) Dan Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4
- (2012) Y. Ren et al. Science Translational Medicine
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Tailoring of Biomimetic High-Density Lipoprotein Nanostructures Changes Cholesterol Binding and Efflux
- (2011) Andrea J. Luthi et al. ACS Nano
- The role of iron in tumour cell proliferation
- (2011) Juan Luis Steegmann-Olmedillas Clinical & Translational Oncology
- A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study
- (2011) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo
- (2011) Justin B. Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Biomimetic High Density Lipoprotein Nanoparticles For Nucleic Acid Delivery
- (2011) Kaylin M. McMahon et al. NANO LETTERS
- Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
- (2011) Warefta Hasan et al. NANO LETTERS
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
- (2010) S. K. Libutti et al. CLINICAL CANCER RESEARCH
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Clinical Developments in Nanotechnology for Cancer Therapy
- (2010) Jeremy D. Heidel et al. PHARMACEUTICAL RESEARCH
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Nanotechnology and Cancer
- (2007) James R. Heath et al. Annual Review of Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started